Details for New Drug Application (NDA): 021210

NDA 021210 describes UNITHROID, which is a drug marketed by Stevens J and is included in one NDA. It is available from five suppliers. Additional details are available on the UNITHROID profile page.

The generic ingredient in UNITHROID is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for 021210

Tradename:	UNITHROID
Applicant:	Stevens J
Ingredient:	levothyroxine sodium
Patents:	0
Formulation / Manufacturing:	see details

Pharmacology for NDA: 021210

Suppliers and Packaging for NDA: 021210

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
UNITHROID	levothyroxine sodium	TABLET;ORAL	021210	NDA	Northwind Pharmaceuticals	51655-453	51655-453-52	30 TABLET in 1 BOTTLE, PLASTIC (51655-453-52)
UNITHROID	levothyroxine sodium	TABLET;ORAL	021210	NDA	Northwind Pharmaceuticals	51655-513	51655-513-52	30 TABLET in 1 BOTTLE, PLASTIC (51655-513-52)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Approval Date:	Aug 21, 2000	TE:	AB1,AB2,AB3	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Approval Date:	Aug 21, 2000	TE:	AB1,AB2,AB3	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium
Approval Date:	Aug 21, 2000	TE:	AB1,AB2,AB3	RLD:	Yes

Complete Access Available with Subscription